Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022

BUY
$82.37 - $107.29 $7.41 Million - $9.66 Million
90,000 New
90,000 $7.44 Million
Q2 2022

Aug 15, 2022

SELL
$86.5 - $128.27 $899,600 - $1.33 Million
-10,400 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$106.37 - $130.68 $2.98 Million - $3.66 Million
-28,000 Reduced 72.92%
10,400 $1.35 Million
Q3 2021

Nov 12, 2021

SELL
$102.91 - $122.75 $11.6 Million - $13.9 Million
-113,200 Reduced 74.67%
38,400 $4.35 Million
Q2 2021

Jul 19, 2021

SELL
$83.84 - $104.76 $8.13 Million - $10.2 Million
-97,000 Reduced 39.02%
151,600 $15.7 Million
Q1 2021

May 11, 2021

SELL
$78.68 - $90.67 $15.2 Million - $17.5 Million
-193,000 Reduced 43.7%
248,600 $20.8 Million
Q4 2020

Feb 11, 2021

SELL
$71.69 - $91.23 $10.1 Million - $12.8 Million
-140,720 Reduced 24.17%
441,600 $40.3 Million
Q3 2020

Nov 13, 2020

BUY
$67.19 - $87.44 $19.5 Million - $25.4 Million
290,720 Added 99.7%
582,320 $46.5 Million
Q2 2020

Aug 13, 2020

BUY
$57.54 - $76.95 $4.64 Million - $6.21 Million
80,700 Added 38.26%
291,600 $20.2 Million
Q1 2020

May 12, 2020

BUY
$52.41 - $81.0 $10.8 Million - $16.7 Million
205,900 Added 4118.0%
210,900 $39.8 Million
Q4 2019

Feb 11, 2020

SELL
$71.7 - $82.09 $3.48 Million - $3.99 Million
-48,600 Reduced 90.67%
5,000 $1.17 Million
Q3 2019

Nov 12, 2019

BUY
$61.55 - $75.43 $3.3 Million - $4.04 Million
53,600 New
53,600 $11.8 Million
Q4 2018

Feb 14, 2019

SELL
$46.41 - $56.94 $3.61 Million - $4.43 Million
-77,776 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$45.7 - $58.03 $3.54 Million - $4.5 Million
77,540 Added 32855.93%
77,776 $13.5 Million
Q2 2018

Aug 01, 2018

BUY
$42.45 - $51.3 $10,018 - $12,106
236 New
236 $34,000
Q1 2018

May 01, 2018

SELL
$37.19 - $47.45 $743,800 - $949,000
-20,000 Closed
0 $0
Q4 2017

Feb 06, 2018

BUY
$33.79 - $39.39 $675,800 - $787,800
20,000
20,000 $2.25 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Mufg Securities Emea PLC Portfolio

Follow Mufg Securities Emea PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mufg Securities Emea PLC, based on Form 13F filings with the SEC.

News

Stay updated on Mufg Securities Emea PLC with notifications on news.